Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

NCT02028221 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT02028221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
March 7, 2014
Completion date
June 14, 2022
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer prevention